HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

EGPAF expansion of HIV and AIDS treatment, prevention programs in six districts in Lesotho

The Elizabeth Glaser Pediatric AIDS Foundation is pleased to announce the expansion of its HIV and AIDS treatment and prevention programs in six districts in Lesotho.

4 Feb 2014

Mylan launches trastuzumab biosimilar for treatment of HER2-positive metastatic breast cancer

Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.

3 Feb 2014

Geranium plant extracts prevent HIV-1 from invading human cells

Extracts of the geranium plant Pelargonium sidoides inactivate human immunodeficiency virus type 1 (HIV-1) and prevent the virus from invading human cells. In the current issue of "PLOS ONE", scientists from the Helmholtz Zentrum München report that these extracts represent a potential new class of anti-HIV-1 agents for the treatment of AIDS.

30 Jan 2014

Researcher to study how to address shortage of mental health services in Vietnam

A Simon Fraser University researcher is going to Vietnam to study how to address the shortage of accessible and adequate services for people with mental disorders like depression and anxiety.

30 Jan 2014

EGPAF donates medical equipment to Swaziland to improve health of mothers and children

The Elizabeth Glaser Pediatric AIDS Foundation in collaboration with Project C.U.R.E (Commission on Urgent Relief and Equipment) today donated medical equipment and supplies worth more than U.S. $500,000 to the Government of the Kingdom of Swaziland's Ministry of Health to help strengthen health services provided to mothers, infants, and children in the country.

30 Jan 2014

Researchers identify unique area of human brain associated with cognitive powers

Oxford University researchers have identified an area of the human brain that appears unlike anything in the brains of some of our closest relatives.

29 Jan 2014

UTSA and Health Science Center receive grant to prevent substance abuse, HIV/AIDS transmission among young adults

The UTSA Institute for Health Disparities Research in the College of Liberal and Fine Arts and The University of Texas Health Science Center at San Antonio Division of Community Pediatrics have been awarded $900,000 in funding from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Prevention (CSAP) for a collaborative project between a Minority-Serving Institution and Community-Based Organization(s) to prevent and reduce Substance Abuse (SA) and HIV/AIDS transmission among young adults.

24 Jan 2014

Mylan Pharmaceuticals launches Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg. This product is the generic version of Novo Nordisk's Prandin, which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

24 Jan 2014

CWRU researchers receive NIAID grant to conduct HIV research and clinical trials

AIDS researchers from Case Western Reserve University and University Hospitals Case Medical Center have received a seven-year funding award from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

23 Jan 2014

Researchers find definitive link between intimate partner violence and HIV risk

Researchers from The Miriam Hospital and the University of Rochester have found a definitive link between violence among intimate partners and an increased risk of HIV infection. The study is online in the journal Women & Health.

23 Jan 2014

Virginia Mason receives Distinguished Hospital Award for Clinical Excellence

Virginia Mason announced today it has received the Distinguished Hospital Award for Clinical Excellence™ for the fourth consecutive year from Healthgrades, an online resource for comprehensive information about U.S. physicians and hospitals.

22 Jan 2014

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

ViiV Healthcare today announced that the European Commission has approved Tivicay (dolutegravir), an integrase inhibitor, for use in combination with other anti-retroviral medicinal products for the treatment of HIV infected adults and adolescents above 12 years of age.

21 Jan 2014

Virginia Mason and Vera Whole Health announce strategic collaboration

Virginia Mason and Vera Whole Health today announced a strategic collaboration that brings Virginia Mason's clinical best practices to Vera Whole Health's employer-funded primary care clinics.

21 Jan 2014

American Diabetes Association receives $5M grant for Pathway to Stop Diabetes program

AstraZeneca and Bristol-Myers Squibb Company today announced that the companies' U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association's Pathway to Stop Diabetes program. The innovative research initiative provides resources and support for a new generation of diabetes researchers and is designed to generate exciting discoveries through excellence, innovation, collaboration and radical thinking.

16 Jan 2014

New drug combination proves effective in treatment of hepatitis C

Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new research at Johns Hopkins and elsewhere.

16 Jan 2014

Smoking and cancer: an interview with Dr. Lewis Foxhall, VP of Health Policy, University of Texas MD Anderson Cancer Center

The report Smoking and Health: Report of the Advisory Committee to the Surgeon General, identified tobacco as the predominant cause of lung cancer in men. This was the first widely disseminated report based on scientific studies showing the clear link between smoking tobacco and serious health conditions including cancer, chronic lung diseases and heart disease.

13 Jan 2014

Researchers develop personalized tool to predict likelihood of prostate cancer overdiagnosis

Studies have found that prostate cancer is overdiagnosed in up to 42 percent of cases, prompting men to receive unnecessary treatment that can cause devastating side effects, including impotence and incontinence.

9 Jan 2014

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Biogen Idec and Sangamo BioSciences, Inc. announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that result from the abnormal structure or underproduction of hemoglobin.

9 Jan 2014

Mylan announces launch of Mycophenolic Acid Delayed-release Tablets

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic Delayed-release Tablets.

9 Jan 2014

Zyomyx's MyT4 point-of-care CD4 diagnostic test receives CE mark approval

Mylan, Inc. today announced that Zyomyx's MyT4 point-of-care CD4 diagnostic test has received the CE Certificate of Conformity in the European Union, an important step toward launching this innovative test and expanding access to affordable, accessible and reliable diagnostics for people living with HIV globally.

9 Jan 2014

HIV/AIDS News and Research

Further Reading

EGPAF expansion of HIV and AIDS treatment, prevention programs in six districts in Lesotho

Mylan launches trastuzumab biosimilar for treatment of HER2-positive metastatic breast cancer

Geranium plant extracts prevent HIV-1 from invading human cells

Researcher to study how to address shortage of mental health services in Vietnam

EGPAF donates medical equipment to Swaziland to improve health of mothers and children

Researchers identify unique area of human brain associated with cognitive powers

UTSA and Health Science Center receive grant to prevent substance abuse, HIV/AIDS transmission among young adults

Mylan Pharmaceuticals launches Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg

CWRU researchers receive NIAID grant to conduct HIV research and clinical trials

Researchers find definitive link between intimate partner violence and HIV risk

Virginia Mason receives Distinguished Hospital Award for Clinical Excellence

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

Virginia Mason and Vera Whole Health announce strategic collaboration

American Diabetes Association receives $5M grant for Pathway to Stop Diabetes program

New drug combination proves effective in treatment of hepatitis C

Smoking and cancer: an interview with Dr. Lewis Foxhall, VP of Health Policy, University of Texas MD Anderson Cancer Center

Researchers develop personalized tool to predict likelihood of prostate cancer overdiagnosis

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Mylan announces launch of Mycophenolic Acid Delayed-release Tablets

Zyomyx's MyT4 point-of-care CD4 diagnostic test receives CE mark approval

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News